22 May 2013
Keywords: ofatumumab, sees, positive, ph, iii, cll, data
Article | 11 August 2008
Danish biotechnology firm Genmab and UK drug major GlaxoSmithKline have reported positive top-line results from an interim analysis of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 August 2008
21 May 2013
© 2013 thepharmaletter.com